Atlas FDA

DBX Demineralized Bone Matrix Putty 10cc-Indicated for treatment of surgically created osseous defects or osseous defect

FDA device recall Z-0323-2024 · posted 2023-11-17 · Open, Classified

Recall details

Recalling firm
Musculoskeletal Transplant Foundation, Inc.
Reason for recall
Units are labeled as 10cc; however the units have a fill volume of 1cc units. This may result in prolongation of surgery.
Action taken
MTF Biologicals issued Voluntary Market Withdrawal Notification Letter via customer service scripts on 9/22/23 and provided written notification via letter and/or Email on 10/3/23 to customers . Letter states reason for recall, health risk and action to take: If the tissue is still available in your inventory, we request you return the tissue to us. We will send a replacement if required. Should you have any questions, please contact Customer Service at 1-800-433-6576, or please feel free to contact me at 732-661-2209, or email MTF Regulatory Affairs at Regulatory_Customer_Inquiry@mtf.org.
Root cause
Labeling Change Control
Status
Open, Classified
Product code
MQV
Quantity affected
18 units
Distribution
US Nationwide distribution in the states of PA, TX, WA.
Date initiated
2023-09-22
Date posted
2023-11-17
Location
Edison, NJ

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
DBX DEMINERALIZED BONE MATRIX PUTTY, BONE MATRIX PASTE AND BONE MATRIX MIX (K040262)Musculoskeletal Transplant Foundation2005-03-17